Literature DB >> 29478593

Prion disease.

Leonel T Takada1, Mee-Ohk Kim2, Stacy Metcalf2, Ignacio Illán Gala3, Michael D Geschwind4.   

Abstract

Genetic prion diseases (gPrDs) are caused by autosomal-dominant mutations in the prion protein gene (PRNP). Although the first PRNP mutations identified, and most since, are PRNP missense, octapeptide repeat insertions, deletion and nonsense mutations have now also been shown to cause gPrD. Based on clinicopathologic features of familial disease, gPrDs historically have been classified into three forms: familial Jakob-Creutzfeldt disease, Gerstmann-Sträussler-Scheinker disease, and fatal familial insomnia. This classification, however, occurred prior to the identification of PRNP, and although these forms are still recognized, classification now is somewhat more complex. Clinical manifestations, and even pathology, are known to be more heterogeneous and varied than the historic three phenotypic classifications. Most gPrDs either present rapidly with progression of dementia, ataxia, myoclonus, and other motor features leading to death in few months or present more slowly, declining over a few years with mild cognitive impairment, ataxia, or parkinsonism and later dementia; a few very rare mutations, however, present over years to decades with neuropsychiatric disorders and systemic symptoms (gastrointestinal disorders and neuropathy). In this chapter, we review the broad phenotypic spectrum of PRNP mutations causing gPrDs.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CJD; Creutzfeldt–Jakob disease; nonsense mutation; octapeptide repeat insertion; prion protein gene; rapidly progressive dementia

Mesh:

Substances:

Year:  2018        PMID: 29478593     DOI: 10.1016/B978-0-444-64076-5.00029-6

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  8 in total

Review 1.  Chronic Wasting Disease (CWD) in Cervids and the Consequences of a Mutable Protein Conformation.

Authors:  Christopher J Silva
Journal:  ACS Omega       Date:  2022-04-04

Review 2.  Myoclonus-Ataxia Syndromes: A Diagnostic Approach.

Authors:  Malco Rossi; Sterre van der Veen; Marcelo Merello; Marina A J Tijssen; Bart van de Warrenburg
Journal:  Mov Disord Clin Pract       Date:  2020-11-03

3.  Analysis of 12 Chinese Patients with Proline-to-Leucine Mutation at Codon 102-Associated Gerstmann-Sträussler-Scheinker Disease.

Authors:  Jing Wang; Kang Xiao; Wei Zhou; Qi Shi; Xiao Ping Dong
Journal:  J Clin Neurol       Date:  2019-03-11       Impact factor: 3.077

4.  Clinicopathological features of the rare form of Creutzfeldt-Jakob disease in R208H-V129V PRNP carrier.

Authors:  Dorina Tiple; Anna Poleggi; Vittorio Mellina; Antonino Morocutti; Livia Brusa; Cesare Iani; Elisa Colaizzo; Luana Vaianella; Simone Baiardi; Anna Ladogana; Piero Parchi; Maurizio Pocchiari
Journal:  Acta Neuropathol Commun       Date:  2019-03-21       Impact factor: 7.801

5.  Corticobasal manifestations of Creutzfeldt-Jakob disease with D178N-homozygous 129M genotype.

Authors:  Yumeng Huang; Ma Jianfang; Rodrigo Morales; Huidong Tang
Journal:  Prion       Date:  2020-12       Impact factor: 3.931

6.  Calcineurin Controls Cellular Prion Protein Expression in Mouse Astrocytes.

Authors:  Giulia Dematteis; Elena Restelli; Virginia Vita Vanella; Marcello Manfredi; Emilio Marengo; Marco Corazzari; Armando A Genazzani; Roberto Chiesa; Dmitry Lim; Laura Tapella
Journal:  Cells       Date:  2022-02-10       Impact factor: 6.600

Review 7.  Dendrimers and Dendritic Materials: From Laboratory to Medical Practice in Infectious Diseases.

Authors:  Miguel Ángel Ortega; Alberto Guzmán Merino; Oscar Fraile-Martínez; Judith Recio-Ruiz; Leonel Pekarek; Luis G Guijarro; Natalio García-Honduvilla; Melchor Álvarez-Mon; Julia Buján; Sandra García-Gallego
Journal:  Pharmaceutics       Date:  2020-09-14       Impact factor: 6.321

8.  Characterization of Prion Disease Associated with a Two-Octapeptide Repeat Insertion.

Authors:  Nicholas Brennecke; Ignazio Cali; Tze How Mok; Helen Speedy; Laszlo L P Hosszu; Christiane Stehmann; Laura Cracco; Gianfranco Puoti; Thomas W Prior; Mark L Cohen; Steven J Collins; Simon Mead; Brian S Appleby
Journal:  Viruses       Date:  2021-09-08       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.